Salvianolate can attenuate bleomycin-induced pulmonary epithelial-mesenchymal transition

Fangfang Wang,Handong Jiang
DOI: https://doi.org/10.1183/13993003.congress-2018.PA4806
IF: 24.3
2018-01-01
European Respiratory Journal
Abstract:Object: To investigate the effects of Salviaenolate on bleomycin-induced epithelial-mesenchymal transition and exlpored the potential role of FXR in it. Methods: The appropriate concentration and duration of bleomycin and salvianolate were screened by Sulforhodamine B method. Western bloting was used to evalute the expressions of mesenchymal markers (vimentin and α-SMA) and to analyze possible signaling pathways. Results: A series of concentrations of bleomycin and salvianolate were respectively given to A549 at concentrations of 0.04-10um and1.56-400ug / ml , then we found IC50 of bleomycin for 4h is 2.8um and 12.5ug / ml salvianolate promote the strongest proliferation. We administered A549 with bleomycin (5um or 2.5um) and 12.5ug / ml salvianolate (pre-treatment for 4h or post-treatment for 72h). A549 treated with salvianolate maintained normal cuboid morphology , while those only given bleomycin shaped to spindle.A549 with salvianolate showed low levels of vimentin andα- SMA compared with bleomycin. FXR and toll-like receptor 4 (TLR4) also exhibited changes consistent with those markers. Conclusion: Our results suggested that Salvianolate can attenuate bleomycin-induced epithelial-mesenchymal transition through FXR pathways.
What problem does this paper attempt to address?